Impact of Screening Patients With HIV for Kidney Disease

This study has been withdrawn prior to enrollment.
(Sufficient study funding was not obtained.)
Sponsor:
Information provided by:
University of Mississippi Medical Center
ClinicalTrials.gov Identifier:
NCT00392132
First received: October 23, 2006
Last updated: November 24, 2008
Last verified: November 2008
  Purpose

The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. This study looks at the effect of this new screening program. Our Hypothesis is that screening for kidney disease is a cost effective and important addition to the care of patients with HIV.


Condition
HIV Infections
Renal Insufficiency, Chronic
Proteinuria

Study Type: Observational
Official Title: Impact of Screening Patients With HIV for Kidney Disease

Resource links provided by NLM:


Further study details as provided by University of Mississippi Medical Center:

Estimated Enrollment: 1400
Study Start Date: October 2005
Estimated Study Completion Date: October 2006
Estimated Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
Detailed Description:

The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. However nobody knows for sure whether this will help doctors take better care of patient with HIV.

This study looks at the effect of this new screening program. We want to see how frequently abnormalities are seen on screening, how frequently certain kidney diseases are diagnosed, how often patients are referred to a nephrologist and how often a patient's management is changed by the screening. We will also estimate the cost-benefit ratio of the screening. We will review patient charts to determine what has happened in each case where screening was conducted.

This study will not involve any additional testing.

The benefit of this study will be improving our understanding of kidney disease in HIV. It will help us determine the value of screening for kidney disease and the frequency of certain kidney diseases in HIV in our clinic population.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients with HIV who are seen by the University of Mississippi Infectious disease clinic at the Jackson Medical Mall or patient seen at the University of Mississippi Nephrology Clinic.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00392132

Locations
United States, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216-4505
Sponsors and Collaborators
University of Mississippi Medical Center
Investigators
Principal Investigator: Darren W Schmidt, MD University of Mississippi Medical Center
  More Information

No publications provided

Responsible Party: Darren Schmidt, Assistant Professor of Medicine, University of Mississippi Medical Center
ClinicalTrials.gov Identifier: NCT00392132     History of Changes
Other Study ID Numbers: UMMC - HIV and CKD
Study First Received: October 23, 2006
Last Updated: November 24, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by University of Mississippi Medical Center:
HIV

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Kidney Diseases
Proteinuria
Renal Insufficiency
Renal Insufficiency, Chronic
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases
Urologic Diseases
Urination Disorders
Urological Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on August 20, 2014